Jim Barrington et al | 27 Oct 2010 | Malaria Journal
The SMS for Life pilot provided visibility of anti-malarial stock levels to support more efficient stock management using simple and widely available SMS technology, via a public-private partnership model that worked highly effectively.
Richard Steketee & Carlos Campbell | 27 Oct 2010 | Malaria Journal
Several factors potentially have contributed to recent health improvement in African countries, but there is substantial evidence that achieving high malaria control intervention coverage, especially with ITNs and targeted IRS, has been the leading contributor to reduced child mortality.
Andreas Kudom & Ben Mensah | 15 Sep 2010 | Malaria Journal
The study reveals that respondents did not have adequate knowledge on the biology and behaviour of mosquitoes.
Frank Smithuis et al | 09 Sep 2010 | The Lancet Infectious Diseases
Artemisinin-combination therapy (ACT) is recommended as first-line treatment of falciparum malaria throughout the world, and fixed-dose combinations are preferred by WHO; whether a single gametocytocidal dose of primaquine should be added is unknown.
Roger Bate, Kimberly Hess & Lorraine Mooney | 02 Sep 2010 | Research and Reports in Tropical Medicine
Antimalarial medicine diversion has been seen across numerous African markets and can lead to serious stock-outs in the public sector, which can be dangerous to countries with high burdens of disease. This study discusses the numbers of diverted antimalarial medicines from several samplings in Africa.
Roger Bate & Kimberly Hess | 13 Aug 2010 | PLoS One
Internet-sourced drugs are often considered suspect. The WHO reports that drugs from websites that conceal their physical address are counterfeit in over 50 percent of cases; the FDA works with the NABP to regularly update a list of websites likely to sell drugs that are illegal or of questionable quality.
Jamie T. Griffin et al | 10 Aug 2010 | PloS Medicine
Over the past
decade malaria intervention coverage has been scaled up across Africa.
However, it remains unclear what overall reduction in transmission is
achievable using currently available tools.
Daudi Simba et al | 10 Aug 2010 | PLoS One
Prompt access to ACT among febrile children was unacceptably low, due mainly to limited availability of subsidised ACT at the location where most caretakers sought care. There is urgent need to accelerate implementation of strategies that
will ensure availability of ACT at an affordable price in remote rural
areas, where the burden of malaria is highest.
Wendy Prudhomme O'Meara et al | 29 Jul 2010 | The Lancet Infectious Diseases
The burden of malaria in countries in sub-Saharan Africa has declined with scaling up of prevention, diagnosis, and treatment. To assess the contribution of specific malaria interventions and other
general factors in bringing about these changes, we reviewed studies
that have reported recent changes in the incidence or prevalence of
malaria in sub-Saharan Africa.
Rosamund Akuse et al | 19 Jul 2010 | Malaria Research and Treatment
Roll Back Malaria Initiative encourages participation of private health
providers in malaria control because mothers seek care for sick children
from them. This study investigated Patent Medicine Sellers (PMS) management of
presumptive malaria in children in order to identify how they can assist